Vaccine maker Moderna joined the S&P500 last week, much to the delight of investors in the company. Trading below $250 in mid-July, the stock briefly exceeded $340 last Tuesday, giving it a market capitalisation of $135 billion ahead of Wednesdays index…

Click here to view the original article.